Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.0687
-0.0019 (-2.72%)
Oct 17, 2025, 10:29 AM EDT
Bio Essence Revenue
Bio Essence had revenue of $259.12 thousand in the quarter ending June 30, 2025, with 521.47% growth. This brings the company's revenue in the last twelve months to $563.56 thousand, down -358.66% year-over-year. In the year 2024, Bio Essence had annual revenue of $323.94 thousand.
Revenue (ttm)
563.56K
Revenue Growth
-358.66%
P/S Ratio
4.63
Revenue / Employee
281.78K
Employees
2
Market Cap
2.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 323.94K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 621.59K | -266.39K | -30.00% |
| Dec 31, 2021 | 887.98K | -70.72K | -7.38% |
| Dec 31, 2020 | 958.70K | 132.39K | 16.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |